Literature DB >> 3553006

Elimination of group A streptococcal cell walls from mammalian tissues.

J Gilbart, A Fox.   

Abstract

The precise levels in mammalian tissues of rhamnose (a constituent of the group-specific polysaccharide) and muramic acid (a constituent of peptidoglycan) at various times after systemic administration of streptococcal cell walls were noted for the first time. The extreme resistance of the streptococcal cell wall to degradation by mammalian enzymes can now be clearly appreciated. The results help explain the chronic nature of certain inflammatory diseases elicited by streptococcal cell wall debris.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3553006      PMCID: PMC260547          DOI: 10.1128/iai.55.6.1526-1528.1987

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  14 in total

1.  Measurement of bacterial cell wall in tissues by solid-phase radioimmunoassay: correlation of distribution and persistence with experimental arthritis in rats.

Authors:  R Eisenberg; A Fox; J J Greenblatt; S K Anderle; W J Cromartie; J H Schwab
Journal:  Infect Immun       Date:  1982-10       Impact factor: 3.441

2.  Degradation of 14C-labeled streptococcal cell walls by egg white lysozyme and lysosomal enzymes.

Authors:  H A Gallis; S E Miller; R W Wheat
Journal:  Infect Immun       Date:  1976-05       Impact factor: 3.441

3.  The metabolic fate of 14C-labeled peptidoglycan monomer in mice. I. Identification of the monomer and the corresponding pentapeptide in urine.

Authors:  J Tomasić; B Ladesić; Z Valinger; I Hrsak
Journal:  Biochim Biophys Acta       Date:  1980-04-17

4.  Uveitis and arthritis induced by systemic injection of streptococcal cell walls.

Authors:  A Wells; G Pararajasegaram; M Baldwin; C H Yang; M Hammer; A Fox
Journal:  Invest Ophthalmol Vis Sci       Date:  1986-06       Impact factor: 4.799

5.  Granulomatous enterocolitis induced in rats by purified bacterial cell wall fragments.

Authors:  R B Sartor; W J Cromartie; D W Powell; J H Schwab
Journal:  Gastroenterology       Date:  1985-09       Impact factor: 22.682

6.  Muramic acid detection in mammalian tissues by gas-liquid chromatography-mass spectrometry.

Authors:  A Fox; J H Schwab; T Cochran
Journal:  Infect Immun       Date:  1980-08       Impact factor: 3.441

7.  Fate of the synthetic immunoadjuvant, muramyl dipeptide (14C-labelled) in the mouse.

Authors:  M Parant; F Parant; L Chedid; A Yapo; J F Petit; E Lederer
Journal:  Int J Immunopharmacol       Date:  1979

8.  Treatment of experimental erosive arthritis in rats by injection of the muralytic enzyme mutanolysin.

Authors:  M J Janusz; C Chetty; R A Eisenberg; W J Cromartie; J H Schwab
Journal:  J Exp Med       Date:  1984-11-01       Impact factor: 14.307

9.  Persistence of group a streptococcal cell walls related to chronic inflammation of rabbit dermal connective tissue.

Authors:  S H Ohanian; J H Schwab
Journal:  J Exp Med       Date:  1967-06-01       Impact factor: 14.307

10.  Arthritis in rats after systemic injection of streptococcal cells or cell walls.

Authors:  W J Cromartie; J G Craddock; J H Schwab; S K Anderle; C H Yang
Journal:  J Exp Med       Date:  1977-12-01       Impact factor: 14.307

View more
  12 in total

1.  Phagocytes containing a disease-promoting Toll-like receptor/Nod ligand are present in the brain during demyelinating disease in primates.

Authors:  Lizette Visser; Marie-José Melief; Debby van Riel; Marjan van Meurs; Ella A Sick; Seiichi Inamura; Jeffrey J Bajramovic; Sandra Amor; Rogier Q Hintzen; Leonie A Boven; Bert A 't Hart; Jon D Laman
Journal:  Am J Pathol       Date:  2006-11       Impact factor: 4.307

2.  Monitoring of bacterial sugars and hydroxy Fatty acids in dust from air conditioners by gas chromatography-mass spectrometry.

Authors:  A Fox; R M Rosario; L Larsson
Journal:  Appl Environ Microbiol       Date:  1993-12       Impact factor: 4.792

3.  Muramic acid is not generally present in the human spleen as determined by gas chromatography-tandem mass spectrometry.

Authors:  Michael P Kozar; Jon D Laman; Alvin Fox
Journal:  Infect Immun       Date:  2002-02       Impact factor: 3.441

4.  Carbohydrate profiling of bacteria by gas chromatography-mass spectrometry: chemical derivatization and analytical pyrolysis.

Authors:  J Gilbart; A Fox; S L Morgan
Journal:  Eur J Clin Microbiol       Date:  1987-12       Impact factor: 3.267

5.  Failure To detect muramic acid in normal rat tissues but detection in cerebrospinal fluids from patients with Pneumococcal meningitis.

Authors:  M P Kozar; M T Krahmer; A Fox; B M Gray
Journal:  Infect Immun       Date:  2000-08       Impact factor: 3.441

6.  Bacterial cell wall-induced arthritis: chemical composition and tissue distribution of four Lactobacillus strains.

Authors:  E Simelyte; M Rimpiläinen; L Lehtonen; X Zhang; P Toivanen
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

7.  Absolute identification of muramic acid, at trace levels, in human septic synovial fluids in vivo and absence in aseptic fluids.

Authors:  A Fox; K Fox; B Christensson; D Harrelson; M Krahmer
Journal:  Infect Immun       Date:  1996-09       Impact factor: 3.441

8.  Enzyme degradation and proinflammatory activity in arthritogenic and nonarthritogenic Eubacterium aerofaciens cell walls.

Authors:  X Zhang; M Rimpiläinen; E Simelyte; P Toivanen
Journal:  Infect Immun       Date:  2001-12       Impact factor: 3.441

9.  Muramic acid is not detectable in Chlamydia psittaci or Chlamydia trachomatis by gas chromatography-mass spectrometry.

Authors:  A Fox; J C Rogers; J Gilbart; S Morgan; C H Davis; S Knight; P B Wyrick
Journal:  Infect Immun       Date:  1990-03       Impact factor: 3.441

10.  Systemic injection of group A streptococcal peptidoglycan-polysaccharide complexes elicits persistent neutrophilia and monocytosis associated with polyarthritis in rats.

Authors:  A F Wells; J A Hightower; C Parks; E Kufoy; A Fox
Journal:  Infect Immun       Date:  1989-02       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.